Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study

Abstract

BACKGROUND: During the 2009 pandemic of an emerging influenza A virus (IAV; H1N1pdm09), data from several European countries indicated that the spread of the virus might have been interrupted by the annual autumn rhinovirus epidemic. We aimed to investigate viral interference between rhinovirus and IAV with use of clinical data and an experimental model. METHODS: We did a clinical data analysis and experimental infection study to investigate the co-occurrence of rhinovirus and IAV in respiratory specimens from adults (≥21 years) tested with a multiplex PCR panel at Yale-New Haven Hospital (CT, USA) over three consecutive winter seasons (Nov 1 to March 1, 2016-17, 2017-18, and 2018-19). We compared observed versus expected co-detections using data extracted from the Epic Systems electronic medical record system. To assess how rhinovirus infection affects subsequent IAV infection, we inoculated differentiated primary human airway epithelial cultures with rhinovirus (HRV-01A; multiplicity of infection [MOI] 0·1) or did mock infection. On day 3 post-infection, we inoculated the same cultures with IAV (H1N1 green fluorescent protein [GFP] reporter virus or H1N1pdm09; MOI 0·1). We used reverse transcription quantitative PCR or microscopy to quantify host cell mRNAs for interferon-stimulated genes (ISGs) on day 3 after rhinovirus or mock infection and IAV RNA on days 4, 5, or 6 after rhinovirus or mock infection. We also did sequential infection studies in the presence of BX795 (6 μM), to inhibit the interferon response. We compared ISG expression and IAV RNA and expression of GFP by IAV reporter virus. FINDINGS: Between July 1, 2016, and June 30, 2019, examination of 8284 respiratory samples positive for either rhinovirus (n=3821) or IAV (n=4463) by any test method was used to establish Nov 1 to March 1 as the period of peak virus co-circulation. After filtering for samples within this time frame meeting the inclusion criteria (n=13 707), there were 989 (7·2%) rhinovirus and 922 (6·7%) IAV detections, with a significantly lower than expected odds of co-detection (odds ratio 0·16, 95% CI 0·09-0·28). Rhinovirus infection of cell cultures induced ISG expression and protected against IAV infection 3 days later, resulting in an approximate 50 000-fold decrease in IAV H1N1pdm09 viral RNA on day 5 post-rhinovirus inoculation. Blocking the interferon response restored IAV replication following rhinovirus infection. INTERPRETATION: These findings show that one respiratory virus can block infection with another through stimulation of antiviral defences in the airway mucosa, supporting the idea that interference from rhinovirus disrupted the 2009 IAV pandemic in Europe. These results indicate that viral interference can potentially affect the course of an epidemic, and this possibility should be considered when designing interventions for seasonal influenza epidemics and the ongoing COVID-19 pandemic. FUNDING: National Institutes of Health, National Institute of General Medical Sciences, and the Yale Department of Laboratory Medicine.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 30

1. 1.

   Schultz-Cherry S Viral interference: the case of influenza viruses. J Infect Dis 2015; 212: 1690–91.

   Not in our library10.1093/infdis/jiv261

2. 2.

   Ånestad G, Nordbø SA. Virus interference. Did rhinoviruses activity hamper the progress of the 2009 influenza A (H1N1) pandemic in Norway? Med Hypotheses 2011; 77: 1132–34.

   Not in our library10.1016/j.mehy.2011.09.021

3. 3.

   Casalegno JS, Ottmann M, Duchamp MB, Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France. Clin Microbiol Infect 2010; 16: 326–29.

   Not in our library10.1111/j.1469-0691.2010.03167.x

4. 4.

   Linde A, Rotzén-Ostlund M, Zweygberg-Wirgart B, Rubinova S, Brytting M. Does viral interference affect spread of influenza? Euro Surveill 2009; 14: 19354.

   Not in our library

5. 5.

   Greer RM, McErlean P, Arden KE, Do rhinoviruses reduce the probability of viral co-detection during acute respiratory tract infections? J Clin Virol 2009; 45: 10–15.

   Not in our library10.1016/j.jcv.2009.03.008

6. 6.

   Achten NB, Wu P, Bont L, Interference between respiratory syncytial virus and human rhinovirus infection in infancy. J Infect Dis 2017; 215: 1102–06.

   Not in our library10.1093/infdis/jix031

7. 7.

   Karppinen S, Toivonen L, Schuez-Havupalo L, Waris M, Peltola V. Interference between respiratory syncytial virus and rhinovirus in respiratory tract infections in children. Clin Microbiol Infect 2016; 22: 208.e1–208.e6.

   Not in our library10.1016/j.cmi.2015.10.002

8. 8.

   Price OH, Sullivan SG, Sutterby C, Druce J, Carville KS. Using routine testing data to understand circulation patterns of influenza A, respiratory syncytial virus and other respiratory viruses in Victoria, Australia. Epidemiol Infect 2019; 147: e221.

   Not in our library10.1017/s0950268819001055

9. 9.

   Arden KE, Greer RM, Wang CYT, Mackay IM. Genotypic diversity, circulation patterns and co-detections among rhinoviruses in Queensland, 2001. Access Microbiol 2020; published online Jan 1..

   Not in our library10.1099/acmi.0.000075

10. 10.
    Virus–virus interactions impact the population dynamics of influenza and the common cold · 2019

    No notice
11. 11.

    Boikos C, Papenburg J, Martineau C, Viral interference and the live-attenuated intranasal influenza vaccine: results from a pediatric cohort with cystic fibrosis. Hum Vaccin Immunother 2017; 13: 1–7.

    Not in our library10.1080/21645515.2017.1287641

12. 12.

    Gonzalez AJ, Ijezie EC, Balemba OB, Miura TA. Attenuation of influenza A virus disease severity by viral coinfection in a mouse model. J Virol 2018; 92: e00881–18.

    Not in our library10.1128/jvi.00881-18

13. 13.

    Landry ML, Foxman EF. Antiviral response in the nasopharynx identifies patients with respiratory virus infection. J Infect Dis 2018; 217: 897–905.

    Not in our library10.1093/infdis/jix648

14. 14.

    Lu X, Schneider E, Jain S, Rhinovirus viremia in patients hospitalized with community-acquired pneumonia. J Infect Dis 2017; 216: 1104–11.

    Not in our library10.1093/infdis/jix455

15. 15.

    Manicassamy B, Manicassamy S, Belicha-Villanueva A, Pisanelli G, Pulendran B, García-Sastre A. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci USA 2010; 107: 11531–36.

    Not in our library10.1073/pnas.0914994107

16. 16.

    Clark K, Plater L, Peggie M, Cohen P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates ser-172 phosphorylation and activation. J Biol Chem 2009; 284: 14136–46.

    Not in our library10.1074/jbc.m109.000414

17. 17.

    Byington CL, Ampofo K, Stockmann C, Community surveillance of respiratory viruses among families in the Utah better identification of germs-longitudinal viral epidemiology (BIG-LoVE) study. Clin Infect Dis 2015; 61: 1217–24.

    Not in our library10.1093/cid/civ486

18. 18.

    Arbefeville S, Ferrieri P. Epidemiologic analysis of respiratory viral infections mainly in hospitalized children and adults in a Midwest University Medical Center after the implementation of a 14-virus multiplex nucleic acid amplification test. Am J Clin Pathol 2017; 147: 43–49.

    Not in our library10.1093/ajcp/aqw185

19. 19.

    Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat Rev Immunol 2014; 14: 315–28.

    Not in our library10.1038/nri3665

20. 20.

    Foxman EF, Iwasaki A. Genome-virome interactions: examining the role of common viral infections in complex disease. Nat Rev Microbiol 2011; 9: 254–64.

    Not in our library10.1038/nrmicro2541

21. 21.

    Jartti T, Jartti L, Peltola V, Waris M, Ruuskanen O. Identification of respiratory viruses in asymptomatic subjects: asymptomatic respiratory viral infections. Pediatr Infect Dis J 2008; 27: 1103–07.

    Not in our library10.1097/inf.0b013e31817e695d

22. 22.
    Viral and Bacterial Interactions in the Upper Respiratory Tract · 2013

    No notice
23. 23.

    Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957; 147: 258–67.

    Not in our library

24. 24.

    Agrawal B Heterologous immunity: role in natural and vaccine-induced resistance to infections. Front Immunol 2019; 10: 2631.

    Not in our library10.3389/fimmu.2019.02631

25. 25.
    Coinfections of the Respiratory Tract: Viral Competition for Resources · 2016

    No notice
26. 26.

    Wolsk HM, Følsgaard NV, Birch S, Picornavirus-induced airway mucosa immune profile in asymptomatic neonates. J Infect Dis 2016; 213: 1262–70.

    Not in our library10.1093/infdis/jiv594

27. 27.

    Yahya M, Rulli M, Toivonen L, Waris M, Peltola V. Detection of host response to viral respiratory infection by measurement of messenger RNA for MxA, TRIM21, and Viperin in nasal swabs. J Infect Dis 2017; 216: 1099–103.

    Not in our library10.1093/infdis/jix458

28. 28.

    Yu J, Peterson DR, Baran AM, Host gene expression in nose and blood for the diagnosis of viral respiratory infection. J Infect Dis 2019; 219: 1151–61.

    Not in our library10.1093/infdis/jiy608

29. 29.

    Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 2014; 32: 513–45.

    Not in our library10.1146/annurev-immunol-032713-120231

30. 30.

    Hamilton JR, Sachs D, Lim JK, Langlois RA, Palese P, Heaton NS. Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity. Proc Natl Acad Sci USA 2016; 113: 3861–66.

    Not in our library10.1073/pnas.1522376113

Cited by papers we hold 4

• Viral Interference between Respiratory Viruses · 2022
  No notice
• Human Rhinovirus Infection Blocks Severe Acute Respiratory Syndrome Coronavirus 2 Replication Within the Respiratory Epithelium: Implications for COVID-19 Epidemiology · 2021
  No notice
• Increased risk of rhinovirus infection in children during the coronavirus disease‐19 pandemic · 2021
  No notice
• Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020 · 2020
  Corrected

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.